Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

574 ARTÍCULOS , VIENDO DEL 16 AL 30

Diabetic Theory in Anti-Alzheimer's Drug Research and Development. Part 2: Therapeutic Potential of cAMP-Specific Phosphodiesterase Inhibitors

Jankowska A, Pawłowski M, Chłoń-Rzepa G.

Curr Med Chem. 2021;28(18):3535-3553. doi: 10.2174/0929867327666200917125857.

Carbon Nano Tubes: Novel Drug Delivery System in Amelioration of Alzheimer's Disease

Mishra J, Kumar B, Pandey M, Pottoo FH, Fayaz F, Khan FA, Sahoo PK.

Comb Chem High Throughput Screen. 2021;24(10):1528-1543. doi: 10.2174/1386207323999200918112538.

Phytochemicals for Drug Discovery in Alzheimer's Disease: In Silico Advances

Sharma S, Bhatia V.

Curr Pharm Des. 2021;27(25):2848-2860. doi: 10.2174/1381612826666200928161721.

Multi-Target Directed Compounds with Antioxidant and/or Anti- Inflammatory Properties as Potent Agents for Alzheimer's Disease

Papagiouvannis G, Theodosis-Nobelos P, Kourounakis PN, Rekka EA.

Med Chem. 2021;17(10):1086-1103. doi: 10.2174/1573406416666201013161303.

Chalcones Acting as Inhibitors of Cholinesterases, β-Secretase and β- Amyloid Aggregation and other Targets for Alzheimer's Disease: A Critical Review

Antoniolli G, Almeida WP, Frias CC, de Oliveira TB.

Curr Med Chem. 2021;28(21):4259-4282. doi: 10.2174/0929867327666201020151804.

Enhancing Therapeutic Efficacy of Donepezil by Combined Therapy: A Comprehensive Review

Rong X, Jiang L, Qu M, Hassan SSU, Liu Z.

Curr Pharm Des. 2021;27(3):332-344. doi: 10.2174/1381612826666201023144836.

Putative Involvement of Endocrine Disruptors in the Alzheimer's Disease Via the Insulin-Regulated Aminopeptidase/GLUT4 Pathway

Ramírez-Expósito MJ, Martínez-Martos JM, Cantón-Habas V, Del Pilar Carrera-González M.

Curr Neuropharmacol. 2021;19(7):939-956. doi: 10.2174/1570159X18666201111103024.

Glia-Driven Neuroinflammation and Systemic Inflammation in Alzheimer's Disease

Hashioka S, Wu Z, Klegeris A.

Curr Neuropharmacol. 2021;19(7):908-924. doi: 10.2174/1570159X18666201111104509.

Naturally Inspired Pyrimidines Analogues for Alzheimer's Disease

Singh S, Dhanawat M, Gupta S, Kumar D, Kakkar S, Nair A, Verma I, Sharma P.

Curr Neuropharmacol. 2021;19(2):136-151. doi: 10.2174/1570159X18666201111110136.

Neuroprotective Effects of Ellagic Acid in Alzheimer's Disease: Focus on Underlying Molecular Mechanisms of Therapeutic Potential

Javaid N, Shah MA, Rasul A, Chauhdary Z, Saleem U, Khan H, Ahmed N, Uddin MS, Mathew B, Behl T, Blundell R.

Curr Pharm Des. 2021;27(34):3591-3601. doi: 10.2174/1381612826666201112144006.

Anti-Neuroinflammatory Potential of Polyphenols by Inhibiting NF-κB to Halt Alzheimer's Disease

Uddin MS, Hasana S, Ahmad J, Hossain MF, Rahman MM, Behl T, Rauf A, Ahmad A, Hafeez A, Perveen A, Ashraf GM.

Curr Pharm Des. 2021;27(3):402-414. doi: 10.2174/1381612826666201118092422.

c-Jun N-Terminal Kinases in Alzheimer's Disease: A Possible Target for the Modulation of the Earliest Alterations

Busquets O, Parcerisas A, Verdaguer E, Ettcheto M, Camins A, Beas-Zarate C, Castro-Torres RD, Auladell C.

J Alzheimers Dis. 2021;82(s1):S127-S139. doi: 10.3233/JAD-201053.

Recent Progress in the Drug Development for the Treatment of Alzheimer's Disease Especially on Inhibition of Amyloid-peptide Aggregation

Liu Y, Cong L, Han C, Li B, Dai R.

Mini Rev Med Chem. 2021;21(8):969-990. doi: 10.2174/1389557520666201127104539.

Current Quest in Natural Bioactive Compounds for Alzheimer's Disease: Multi-Targeted-Designed-Ligand Based Approach with Preclinical and Clinical Based Evidence

Iqubal A, Rahman SO, Ahmed M, Bansal P, Haider MR, Iqubal MK, Najmi AK, Pottoo FH, Haque SE.

Curr Drug Targets. 2021;22(6):685-720. doi: 10.2174/1389450121999201209201004.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias